Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients.

Cerea, K; Romano, F; Bravo, A F; Motta, V; Uggeri, F; Brivio, F; Fumagalli, L A; Uggeri, F

Cerea, K; Romano, F; Bravo, A F; Motta, V; Uggeri, F; Brivio, F; Fumagalli, L A; Uggeri, F.

Affiliation

Cerea K; 1(st) General Surgery Department, II University of Milano-Bicocca, San Gerardo Hospital-Monza (Milano), Italy.

J Surg Oncol ; 78(1): 32-7, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11519066

Subject(s)

Adenocarcinoma/surgery; Immunologic Deficiency Syndromes/prevention & control; Interleukin-2/administration & dosage; Preoperative Care; Stomach Neoplasms/surgery; Adenocarcinoma/complications; Adult; Aged; CD4 Lymphocyte Count; Drug Administration Schedule; Female; Gastrectomy; Humans; Immunologic Deficiency Syndromes/etiology; Injections, Subcutaneous; Male; Middle Aged; Stomach Neoplasms/complications; T-Lymphocytes, Helper-Inducer/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Preoperative Care / Adenocarcinoma / Interleukin-2 / Immunologic Deficiency Syndromes Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Surg Oncol Year: 2001 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links